Ticker Details
Pliant Therapeutics, Inc.
IPO Date:	June 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$74.92M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 3.17%
Avg Daily Range (30 D):	$0.02 | 1.65%
Avg Daily Range (90 D):	$0.03 | 2.38%

Institutional Daily Volume
Avg Daily Volume:	.57M
Avg Daily Volume (30 D):	.48M
Avg Daily Volume (90 D):	.62M

Trade Size
Avg Trade Size (Sh.):	108
Avg Trade Size (Sh.) (30 D):	293
Avg Trade Size (Sh.) (90 D):	290

Institutional Trades
Total Institutional Trades:	1,078
Avg Institutional Trade:	$1.5M
Avg Institutional Trade (30 D):	$.6M
Avg Institutional Trade (90 D):	$.6M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.58M
Avg Closing Trade (30 D):	$.61M
Avg Closing Trade (90 D):	$.61M
Avg Closing Volume:	102.46K

News

Apr 18, 2026 @ 5:31 PM Pliant Therapeutics Announces Presentation of Upda... Source: Na

Mar 23, 2025 @ 12:34 PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates ... Source: N/A

Feb 7, 2025 @ 9:58 PM Pliant Therapeutics Provides Update on BEACON-IPF,... Source: N/A

Nov 18, 2024 @ 11:00 PM Pliant Therapeutics Presents Data from its Bexoteg... Source: N/A

Jul 13, 2024 @ 1:35 AM Pliant Therapeutics CBO sells shares worth over $1... Source: Investing.Com

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.84	$-.32	$-.38
Diluted EPS	$-1.84	$-.32	$-.38
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-113.22M	$-20.04M	$-23.58M
Operating Income / Loss	$-119.21M	$-21.77M	$-23.58M
Cost of Revenue
Net Cash Flow	$-69.75M	$-23.26M	$-48.29M
PE Ratio